Inovio Pharmaceuticals (INO) EBIT Margin (2010 - 2025)
Inovio Pharmaceuticals (INO) reported EBIT Margin of -132871.32% for FY2025, down 81254.40 percentage points from -51616.91% in FY2024.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) EBIT Margin (2010 - 2025) Analysis & Trends
Dating back to FY2009, Inovio Pharmaceuticals' EBIT Margin record includes 17 years.
- EBIT Margin has declined for three consecutive years, with a five-year change of -131197.07 percentage points (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual EBIT Margin in data going back to FY2009.
- According to Business Quant data, EBIT Margin came in at -51616.91% in FY2024 (-34316.64 pp), -17300.28% in FY2023 (-14692.92 pp), -2607.35% in FY2022 (+14364.98 pp) and -16972.34% in FY2021 (-15298.09 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Inovio Pharmaceuticals | 73.53 Mn | -110.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -38,336.97% |
| Dec 31, 2024 | -17,410.77% |
| Jun 30, 2024 | -32,945.87% |
| Dec 31, 2023 | -26,686.29% |
| Sep 30, 2023 | -9,152.63% |
| Jun 30, 2023 | -16,391.97% |
| Mar 31, 2023 | -38,238.24% |
| Dec 31, 2022 | -44,876.83% |
| Sep 30, 2022 | -390.61% |
| Jun 30, 2022 | -13,276.13% |
| Mar 31, 2022 | -36,033.33% |
| Dec 31, 2021 | -12,573.76% |
| Sep 30, 2021 | -20,553.16% |
| Jun 30, 2021 | -30,496.56% |
| Mar 31, 2021 | -14,161.05% |
| Dec 31, 2020 | -525.74% |
| Sep 30, 2020 | -15,382.23% |
| Jun 30, 2020 | -12,418.60% |
| Mar 31, 2020 | -1,901.06% |
| Dec 31, 2019 | -10,884.56% |
API Access
Inovio Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();